Average estimated procedure costs, with cost breakdown, for each service volume scenario (USD 2015), intention-to-treat analysis.

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding any HCV therapy costs) stratified by age, discounting, fibrosis stage and SVR.

Phil McEwan (688067)
Thomas Ward (688068)
Hayley Bennett (688069)
Anupama Kalsekar (688070)
Samantha Webster (688071)
Michael Brenner (688072)
Yong Yuan (253559)

January 2015

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding ...

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 20...

Explanation of cost analysis.

Robert L. Schmidt (764529)
Brandon S. Walker (764525)
Michael B. Cohen (440036)

August 2015

The mathematical model estimates sampling performance (number of needle passes, number of procedu...

Costs by procedure and calculation of the total price of each variety of treatment found in the present study.

Ana Cubo Nava (6194942)
Zandra M. Soto Pino (6194945)
Ana M. Haro Pérez (6194948)
M. Estrella Hernández Hernández (6194951)
M. José Doyague Sánchez (6194954)
José M. Sayagués Manzano (6194957)

January 2019

Costs by procedure and calculation of the total price of each variety of treatment found in the pres...

Average estimated procedure costs for each scenario (USD 2013), cost ranges for sensitivity analysis.

Naomi Lince-Deroche (700158)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

November 2015

*Range represents 25% lower and higher than base case. These boundaries were used for the sensiti...

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenario), intention-to-treat analysis.

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenar...

Estimated per syringe and per client costs of a comprehensive syringe service program (SSP) by size and geographic location, United States (in 2016 US dollars).

Eyasu H. Teshale (6640655)
Alice Asher (6640658)
Maria V. Aslam (6640661)
Ryan Augustine (6640664)
Eliana Duncan (6640667)
Alyson Rose-Wood (6640670)
John Ward (332385)
Jonathan Mermin (184948)
Kwame Owusu-Edusei (6640673)
Patricia M. Dietz (836942)

April 2019

Estimated per syringe and per client costs of a comprehensive syringe service program (SSP) by size ...

Average costs per patient when introducing drugs and considering their efficacy.

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Average costs per patient when introducing drugs and considering their efficacy.</p

Cost-analyses: Units of resource use, unit costs, valuation method and volume source (2014 €).

Liv Freeman (5685656)
Johanna Middeldorp (5848442)
Eline van den Akker (5848445)
Martijn Oudijk (3521930)
Caroline Bax (3521936)
Marloes van Huizen (5848448)
Celine Radder (5848451)
Bianca Fong (5848454)
Kitty Bloemenkamp (3521918)
Albert Dahan (282631)
Michel Struys (5848457)
Ben Willem Mol (3342014)
Jan van Lith (5848460)
Elske van den Akker-van Marle (4339039)

October 2018

Cost-analyses: Units of resource use, unit costs, valuation method and volume source (2014 €).</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Estimated costs of a comprehensive syringe service program (SSP) by size and geographic location, United States (in $1,000 2016 US dollars).

Eyasu H. Teshale (6640655)
Alice Asher (6640658)
Maria V. Aslam (6640661)
Ryan Augustine (6640664)
Eliana Duncan (6640667)
Alyson Rose-Wood (6640670)
John Ward (332385)
Jonathan Mermin (184948)
Kwame Owusu-Edusei (6640673)
Patricia M. Dietz (836942)

April 2019

Estimated costs of a comprehensive syringe service program (SSP) by size and geographic location, Un...

Estimated examination and testing cost per EA in the study EAs and across the study area, by costing category (USD).

Emma Harding-Esch (372207)
Mireia Jofre-Bonet (728653)
Jaskiran K. Dhanjal (728654)
Sarah Burr (728655)
Tansy Edwards (122527)
Martin Holland (728656)
Ansumana Sillah (211335)
Sheila West (265440)
Tom Lietman (421435)
Jeremy Keenan (267237)
David Mabey (37055)
Robin Bailey (62493)

April 2015

Estimated examination and testing cost per EA in the study EAs and across the study area, by cost...

Total cost of diagnostic and treatment programme and cost per case and per suspect by scenario [2011 USD].

Gesine Meyer-Rath (144675)
Kathryn Schnippel (320845)
Lawrence Long (320846)
William MacLeod (320847)
Ian Sanne (170641)
Wendy Stevens (62288)
Sagie Pillay (320848)
Yogan Pillay (320849)
Sydney Rosen (213204)

February 2013

Total cost of diagnostic and treatment programme and cost per case and per suspect by scenario [2...

Analysis of median direct and indirect treatment costs per patient among treatment groups.

Adriano Curti (3145368)
Albin Schwarz (3145371)
Johannes Trachsler (3145365)
Yuki Tomonaga (430247)
Patrice M. Ambühl (3145374)

July 2016

Analysis of median direct and indirect treatment costs per patient among treatment groups.</p

Cost-analysis of different strategies per 1000 patients undergoing prosthetic joint or cardiopulmonary surgery.

Marjan W. M. Wassenberg (245517)
G. Ardine de Wit (245519)
Marc J. M. Bonten (109524)

February 2013

Cost-analysis of different strategies per 1000 patients undergoing prosthetic joint or cardiopulm...

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding any HCV therapy costs) stratified by age, discounting, fibrosis stage and SVR.

Phil McEwan (688067)
Thomas Ward (688068)
Hayley Bennett (688069)
Anupama Kalsekar (688070)
Samantha Webster (688071)
Michael Brenner (688072)
Yong Yuan (253559)

January 2015

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding ...

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 20...

Explanation of cost analysis.

Robert L. Schmidt (764529)
Brandon S. Walker (764525)
Michael B. Cohen (440036)

August 2015

The mathematical model estimates sampling performance (number of needle passes, number of procedu...

Costs by procedure and calculation of the total price of each variety of treatment found in the present study.

Ana Cubo Nava (6194942)
Zandra M. Soto Pino (6194945)
Ana M. Haro Pérez (6194948)
M. Estrella Hernández Hernández (6194951)
M. José Doyague Sánchez (6194954)
José M. Sayagués Manzano (6194957)

January 2019

Costs by procedure and calculation of the total price of each variety of treatment found in the pres...

Average estimated procedure costs for each scenario (USD 2013), cost ranges for sensitivity analysis.

Naomi Lince-Deroche (700158)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

November 2015

*Range represents 25% lower and higher than base case. These boundaries were used for the sensiti...

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenario), intention-to-treat analysis.

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenar...

Estimated per syringe and per client costs of a comprehensive syringe service program (SSP) by size and geographic location, United States (in 2016 US dollars).

Eyasu H. Teshale (6640655)
Alice Asher (6640658)
Maria V. Aslam (6640661)
Ryan Augustine (6640664)
Eliana Duncan (6640667)
Alyson Rose-Wood (6640670)
John Ward (332385)
Jonathan Mermin (184948)
Kwame Owusu-Edusei (6640673)
Patricia M. Dietz (836942)

April 2019

Estimated per syringe and per client costs of a comprehensive syringe service program (SSP) by size ...

Average costs per patient when introducing drugs and considering their efficacy.

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Average costs per patient when introducing drugs and considering their efficacy.</p

Cost-analyses: Units of resource use, unit costs, valuation method and volume source (2014 €).

Liv Freeman (5685656)
Johanna Middeldorp (5848442)
Eline van den Akker (5848445)
Martijn Oudijk (3521930)
Caroline Bax (3521936)
Marloes van Huizen (5848448)
Celine Radder (5848451)
Bianca Fong (5848454)
Kitty Bloemenkamp (3521918)
Albert Dahan (282631)
Michel Struys (5848457)
Ben Willem Mol (3342014)
Jan van Lith (5848460)
Elske van den Akker-van Marle (4339039)

October 2018

Cost-analyses: Units of resource use, unit costs, valuation method and volume source (2014 €).</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Estimated costs of a comprehensive syringe service program (SSP) by size and geographic location, United States (in $1,000 2016 US dollars).

Eyasu H. Teshale (6640655)
Alice Asher (6640658)
Maria V. Aslam (6640661)
Ryan Augustine (6640664)
Eliana Duncan (6640667)
Alyson Rose-Wood (6640670)
John Ward (332385)
Jonathan Mermin (184948)
Kwame Owusu-Edusei (6640673)
Patricia M. Dietz (836942)

April 2019

Estimated costs of a comprehensive syringe service program (SSP) by size and geographic location, Un...

Estimated examination and testing cost per EA in the study EAs and across the study area, by costing category (USD).

Emma Harding-Esch (372207)
Mireia Jofre-Bonet (728653)
Jaskiran K. Dhanjal (728654)
Sarah Burr (728655)
Tansy Edwards (122527)
Martin Holland (728656)
Ansumana Sillah (211335)
Sheila West (265440)
Tom Lietman (421435)
Jeremy Keenan (267237)
David Mabey (37055)
Robin Bailey (62493)

April 2015

Estimated examination and testing cost per EA in the study EAs and across the study area, by cost...

Total cost of diagnostic and treatment programme and cost per case and per suspect by scenario [2011 USD].

Gesine Meyer-Rath (144675)
Kathryn Schnippel (320845)
Lawrence Long (320846)
William MacLeod (320847)
Ian Sanne (170641)
Wendy Stevens (62288)
Sagie Pillay (320848)
Yogan Pillay (320849)
Sydney Rosen (213204)

February 2013

Total cost of diagnostic and treatment programme and cost per case and per suspect by scenario [2...

Analysis of median direct and indirect treatment costs per patient among treatment groups.

Adriano Curti (3145368)
Albin Schwarz (3145371)
Johannes Trachsler (3145365)
Yuki Tomonaga (430247)
Patrice M. Ambühl (3145374)

July 2016

Analysis of median direct and indirect treatment costs per patient among treatment groups.</p

Cost-analysis of different strategies per 1000 patients undergoing prosthetic joint or cardiopulmonary surgery.

Marjan W. M. Wassenberg (245517)
G. Ardine de Wit (245519)
Marc J. M. Bonten (109524)

February 2013

Cost-analysis of different strategies per 1000 patients undergoing prosthetic joint or cardiopulm...

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding any HCV therapy costs) stratified by age, discounting, fibrosis stage and SVR.

Phil McEwan (688067)
Thomas Ward (688068)
Hayley Bennett (688069)
Anupama Kalsekar (688070)
Samantha Webster (688071)
Michael Brenner (688072)
Yong Yuan (253559)

January 2015

Estimated per patient costs (£000s) related specifically to HCV related complications (excluding ...

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 2013).

Lionel Perrier (4736739)
Pauline Rascle (5066282)
Magali Morelle (4736748)
Maud Toulmonde (3728575)
Dominique Ranchere Vince (5066276)
Axel Le Cesne (4015952)
Philippe Terrier (304127)
Agnès Neuville (154344)
Pierre Meeus (3451424)
Fadila Farsi (3715723)
Françoise Ducimetière (346737)
Jean-Yves Blay (72864)
Isabelle Ray Coquard (5066279)
Jean-Michel Coindre (154348)

April 2018

Expected costs per patient for base-case, high cost, and low cost estimate scenarios (in € for 20...

Explanation of cost analysis.

Robert L. Schmidt (764529)
Brandon S. Walker (764525)
Michael B. Cohen (440036)

August 2015

The mathematical model estimates sampling performance (number of needle passes, number of procedu...

Average estimated procedure costs, with cost breakdown, for each service volume scenario (USD 2015), intention-to-treat analysis.

Abstract

Extracted data

Average estimated procedure costs, with cost breakdown, for each service volume scenario (USD 2015), intention-to-treat analysis.

Abstract

Extracted data

Related items

Related items